Delivery Order SPE2DB20D3101-SPE2DB24FRPX1
Award Date
7/12/24
Potential Completion Date
7/15/24
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Estrace 0.01% cream, a medication used for various medical conditions. The contract has a ceiling value of $1,237.72 and is a firm fixed price delivery order with a completion date of July 2, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estrace 0.01% cream. The $1,534.97 firm fixed-price contract has a completion date of May 25, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The contract award is...
This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the pharmaceutical product Estrace 0.01% Cream, 42.5 grams. The contract has a ceiling value of $1,688.88 and a period of performance through March 3, 2022. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,778.64 for the supply of Estrace 0.01% Cream 42.5GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, on January 5, 2023, with a completion date of January 6, 2023. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen is a major pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide Estrace 0.01% cream. The contract is a firm fixed price delivery order with a ceiling value of $1,736.50 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp. is the prime contractor for this award, which does not have a set-aside designation. The contract is a part of...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) for the supply of Estradiol 0.01% cream. The contract has a ceiling value of $1,708.33 and a period of performance through April 3, 2023. Amerisourcebergen, a major pharmaceutical distributor, has a significant IDC with DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Estrace 0.01% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,513.26, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 2, 2023. The contract has a completion date of June 5, 2023 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estradiol 0.01% cream. The contract has a firm fixed price of $1,552.80 and a period of performance through April 29, 2025. The award is not associated with a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to the DLA,...
This federal contract award, valued at $4,486.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,559,669,569 ESTRACE 1 MG TABLET 100S, with a completion date of January 23, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization that specializes in pharmaceutical distribution. The company holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Estradiol 0.01% cream. The contract has a firm fixed price of $1,048.62 and an ultimate completion date of June 18, 2024. It is not designated as a set-aside contract. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...